Several companies have reported their financial results for the fourth quarter and full year of 2024. GeneDx Holdings Corp. ($WGS) reported fourth quarter revenues of $95.3 million, up 64% year-over-year, with an adjusted net income of $16.8 million and adjusted gross margins expanding to 70%. The company also issued guidance for 2025, expecting revenues between $350 million and $360 million, with adjusted gross margins projected at 65% to 67%. Vulcan Materials Company ($VMC) reported fourth quarter revenue of $1.85 billion, a 1.09% increase year-over-year, beating estimates by $44 million, and an adjusted EPS of $2.17, surpassing estimates by $0.42 and showing a 48.63% year-over-year increase. Watsco Inc. ($WSO) reported fourth quarter EPS of $2.37 and revenue of $1.75 billion, both beating estimates, with a 17% year-over-year increase in net income and an 11% dividend raise. The Chemours Company ($CC) reported fourth quarter adjusted EPS of $0.11, missing estimates by $0.05, with revenue of $1.36 billion in line with expectations. Fluor Corporation ($FLR) reported fourth quarter revenue of $4.3 billion, up from $3.8 billion the previous year, with a consolidated segment profit of $206 million compared to $85 million last year. Fluor provided 2025 EBITDA guidance of $575 million to $675 million and operating cash flow guidance of $450 million to $500 million. Other companies such as NeoGenomics Inc. ($NEO), Genuine Parts Company ($GPC), Valmont Industries Inc. ($VMI), and Donnelley Financial Solutions Inc. ($DFIN) also reported their fourth quarter results, with varying degrees of performance against estimates.